U.S. Senate Committee Advances Bills to Reform Pharmaceutical Patents and Combat High Drug Prices

In a recent development, a U.S. Senate panel has taken significant steps by approving a series of bills aimed at addressing issues related to pharmaceutical patents and drug pricing. This legislative initiative includes measures designed to confront contentious practices such as patent thickets and “product hopping,” tactics often criticized for stifling competition and maintaining high drug prices. For more details on the legislative proceedings, visit the full article.